5-METHYL-1,3,4-OXADIAZOL-2-YL COMPOUNDS

or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treatment of neurodegenerative diseases and disorders, such as Alzheimer's disease.

Saved in:
Bibliographic Details
Main Authors DREYFUS, Nicolas Jacques Francois, LINDSAY-SCOTT, Peter James, RATHMELL, Richard Edmund
Format Patent
LanguageEnglish
French
German
Published 14.12.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treatment of neurodegenerative diseases and disorders, such as Alzheimer's disease.
Bibliography:Application Number: EP20180729282